Steroid-eluting sinus implant for in-office treatment of recurrent nasal polyposis: a prospective, multicenter study
International forum of allergy & rhinology | 7 Mar 2014
F Lavigne, SK Miller, AR Gould, BJ Lanier and JL Romett
Treatment options for chronic rhinosinusitis with recurrent polyposis (CRSwNP) after endoscopic sinus surgery (ESS) are limited, and include frequent use of systemic steroids and revision surgery. A bioabsorbable, steroid-eluting implant was studied for its ability to dilate sinuses obstructed by polyps and provide localized, controlled steroid delivery to reestablish sinus patency. This study assessed the initial feasibility, safety, and efficacy of steroid-eluting implants placed in the office setting in patients who were candidates for revision ESS.
* Data courtesy of Altmetric.com